Expression profiling of PFKFB3 mRNA levels (GEO accession number GSE13280) in mononuclear cells isolated from bone marrow samples from pediatric B-precursor ALL patients responsive to radiotherapy before (n=11) and after (n=11) radiotherapy, pediatric ALL patients resistant to radiotherapy before (n=11) and after (n=11) radiotherapy. Tukey's multiple comparisons test was used to calculate significance, ** P<0.01. Representative immunoblots (of n > 3 independent experiments) in U2OS cells, β-actin or β-tubulin were used as a loading controls. a, Cells were pre-treated with 10 µM ATM inhibitor, 2.5 µM ATR inhibitor, 2 µM DNAPK inhibitor or DMSO, irradiated (6 Gy) or left untreated, and harvested at indicated time points. b, H2AX levels of cells treated with siH2AX or siControl for 24 h. c, MDC1 levels in cells treated with siMDC1 or siControl for 24 h and 48 h. d, PFKFB3 levels in cells treated with siPFKFB3#1 and siPFKFB3#2 or siControl for 24 h and 48 h. e, RAD51 levels of U2OS cells treated with siRAD51 or siControl for 24 h and 48 h. f, RRM2 levels of U2OS cells treated with siRRM2 or siControl for 24 h.
Supplementary

Supplementary Figure 3.
PFKFB3 is recruited by ATM and the MRN complex upon IR. a, Representative confocal images (of n > 2) of yH2AX and PFKFB3 nuclear recruitment after in situ fractionation in BJ RAS cells upon 6 h treatment with indicated inhibitor, exposed to IR (6 Gy, 0.5 h recovery) or left untreated. Scale bar, 10 µm. b, Scatter plot representing PFKFB3 (left) and yH2AX (right) nuclear intensity in (a) quantified using CellProfiler, > 100 cells / condition. *** P<0.001. c, Confocal analysis of nuclear PFKFB3 in U2OS cells treated with 500µM Mirin inhibitor for 2 h or DMSO followed by IR (6 Gy, 2 h recovery), or left untreated. Scale bar, 10 µm. To the right, scatter plot showing PFKFB3 nuclear intensity in U2OS cells pre-treated with 500µM Mirin inhibitor for 2 h or DMSO and then irradiated at indicated Gy. Cells were fixed 2 h postirradiation, >100 cells/condition (n = 2 independent experiments). Scale bar, 10 µm. *** P<0.001. One-way ANOVA was used to calculate statistical significance. in U2OS cells following 6 h treatment with DMSO or 10 µM 3-PO, exposed to IR (6Gy, 2h recovery) or left untreated. Scale bar, 10 µm. b, Scatter dot plot representing the intensity of RAD51 or RPA32 in (a) as assessed by quantifying nuclear intensity using CellProfiler, n > 500 cells/treatment (n = 3 independent experiments). ANOVA was used to calculate statistical significance, ** P<0.01. c, HR activity of U2OS DR-GFP cells treated with indicated inhibitors as assessed by FACS analysis. DMSO treated cells are taken as reference cells (100% activity), data are displayed as means ± SEM, n=3. One-way ANOVA was used to calculate statistical significance, *** P<0.001. d, Chemical structure of 3-PO inhibitor. To the right, inhibition of recombinant human PFKFB3 by increasing concentrations of 3-PO as assessed by the ADP-GLO assay. Data are displayed as mean ± SD, n = 2. e, Summary of 3-PO inhibition of human PFKFB3. First column shows IC 50 value of 3-PO using the ADP-GLO assay, second column indicates IC 50 value for the formation of F-2,6-P 2 in PANC-1 cells using the biochemical van Schaftingen assay. Last two columns indicate IC 50 values of cell viability assays in PANC-1 and SW620 cells using the SRB assay, n = 2. To the right, representative curve of intracellular F-2,6-P 2 levels in Panc-1 cells, n = 5 independent experiments. f, Cell viability (5 % serum) in indicated cell lines treated with KAN0438757 for 72 h assessed by two methods: the SRB assay and CellTiterGlo. The table holds mean IC 50 ± SD. To the right, representative cell viability curve in PANC-1 using the SRB method, n = 3 independent experiments. g, Polar circle diagram displaying selectivity profile of KAN0438757 (blue) and KAN0438241 (red) for 97 kinases in the DiscoveRx's diverse scanEDGE sm / KINOMEscan set of kinases. The red circle in the middle represents the cut-off value for significant binding. The number labels represent each kinase (see Supplementary Data information to identify each kinase). N = number of test occasions.
Supplementary Figure 7.
Thermal shift of PFKFB3 with KAN0438757 a, Representative immunoblot (of n = 2) to assess target engagement and thermal stabilization of PFKFB3 by 10 µM KAN757 treatment for 24 h compared to DMSO in U2OS cells. b, Representative immunoblot (of n = 2) to assess target engagement and thermal stabilization of PFKFB3 by 10 µM KAN757 treatment for 72 h compared to DMSO in U2OS cells. c, Percentage of non-denatured PFKFB3 relative to DMSO in (a, 24h treatment). Densitometric quantification of band intensities was performed using Image J, PFKBF3 levels were normalized against SOD1. d, Percentage of non-denatured PFKFB3 relative to DMSO in (b, 72h treatment). Densitometric quantification of band intensities was performed using Image J, PFKBF3 levels were normalized against SOD1.
Supplementary Figure 8. PFKFB3 acts downstream of the MRN complex. a,
Representative confocal images (of n = 2) of Nbs1 in U2OS cells pre-treated with 10 µM KAN757 (6 h) or 500µM Mirin (2 h), exposed to IR (6 Gy, 2 h recovery) or left untreated. Scale bar, 10 µm. b, Representative confocal images (of n = 2) of Mre11 in U2OS cells pre-treated with 10 µM KAN757 (6 h) or 500µM Mirin (2 h), exposed to IR (6 Gy, 2 h recovery) or left untreated. c, DNA histograms of U2OS cells treated with indicated inhibitors for 2 h following IR at 2 Gy (24 h recovery) or treated for 72 h (non-irradiated). Cells were fixed and DNA content was assessed using propidium iodide staining and flow cytometry. Data are displayed as mean +/-SEM, n=3. ** P<0.01, *** P<0.001; One-way ANOVA . d, Clonogenic survival of BJ RAS cells transfected with empty vector or GFP-RAD51 plasmid and treated with indicated concentrations of KAN757 or vehicle. Cells were exposed to IR (2Gy) and inhibitors washed out 72 h post IR. Colonies were fixed after 12 days and stained with 4 % methylene blue in MeOH. To the right, representative immunoblot of empty vector and GFP-RAD51 transfected cells to confirm overexpression of RAD51. Data are displayed over DMSO empty vector or DMSO GFP-RAD51 correspondingly, mean +/-SEM, n=3. * P<0.05, *** P<0.001. One-way ANOVA was used to calculate statistical significance. 
